Should we start screening for anal squamous intra-epithelial lesions in HIV-infected homosexual men?

References

[1]  Wilson JWG, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organization; 1968. Available online at: http://whqlibdoc.who.int/php/WHO_PHP_34.pdf [verified March 2011].

[2]  Djulbegovic M, Beyth RJ, Neuberger MM, Stoffs TL, Vieweg J, Djulbegovic B, et al Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ 2010; 341 c4543
| Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials.Crossref | GoogleScholarGoogle Scholar | 20843937PubMed |

[3]  Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al Screening and prostate cancer mortality in a randomized European study. N Engl J Med 2009; 360 1320–8.
| Screening and prostate cancer mortality in a randomized European study.Crossref | GoogleScholarGoogle Scholar | 19297566PubMed |

[4]  D’Souza G, Wiley DJ, Li X, Chmiel JS, Margolick JB, Cranston RD, et al Incidence and epidemiology of anal cancer in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 2008; 48 491–9.
| Incidence and epidemiology of anal cancer in the Multicenter AIDS Cohort Study.Crossref | GoogleScholarGoogle Scholar | 18614927PubMed |

[5]  Piketty C, Selinger-Leneman H, Grabar S, Duvivier C, Bonmarchand M, Abramowitz L, et al Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS 2008; 22 1203–11.
| Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy.Crossref | GoogleScholarGoogle Scholar | 18525266PubMed |

[6]  Gustafsson L, Ponten J, Bergstrom R, Adami HO. International incidence rates of invasive cervical cancer before cytological screening. Int J Cancer 1997; 71 159–65.
| International incidence rates of invasive cervical cancer before cytological screening.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2s3osVChsA%3D%3D&md5=bd0110c82d79e4ba6e3f1ef01038541dCAS | 9139836PubMed |

[7]  Botes LP, Jin F, Bourne C, Pett S, Marriott D, Carr A, et al Participants’ perspectives of self-collected anal cytological swabs. Sex Health 2011; 8 256–7.
| Participants’ perspectives of self-collected anal cytological swabs.Crossref | GoogleScholarGoogle Scholar |

[8]  van der Helm JJ, Hoebe CJ, van Rooijen MS, Brouwers EE, Fennema HS, Thiesbrummel HF, et al High performance and acceptability of self-collected rectal swabs for diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in men who have sex with men and women. Sex Transm Dis 2009; 36 493–7.
| High performance and acceptability of self-collected rectal swabs for diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in men who have sex with men and women.Crossref | GoogleScholarGoogle Scholar | 19617869PubMed |

[9]  Hillman RJ, Pett S, Marriott D, Carr A, Cooper DA, Matthews GV, et al Participants’ perspectives of high resolution anoscopy. Sex Health 2011; 8 254–5.
| Participants’ perspectives of high resolution anoscopy.Crossref | GoogleScholarGoogle Scholar |

[10]  Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 1999; 281 1822–9.
| The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK1M3ntVWqtw%3D%3D&md5=a375ec1c709f4feffb245975206d1ce7CAS | 10340370PubMed |

[11]  Czoski-Murray C, Karnon J, Jones R, Smith K, Kinghorn G. Cost-effectiveness of screening high-risk HIV-positive men who have sex with men and HIV-positive women for anal cancer. Health Technol Assess 2010; 14 1–101.

[12]  Piketty C, Darragh TM, Heard I, Da Costa M, Bruneval P, Kazatchkine MD, et al High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis 2004; 31 96–9.
| High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy.Crossref | GoogleScholarGoogle Scholar | 14743072PubMed |

[13]  Kreuter A, Potthoff A, Brockmeyer NH, Gambichler T, Swoboda J, Stucker M, et al Anal carcinoma in human immunodeficiency virus-positive men: results of a prospective study from Germany. Br J Dermatol 2010; 162 1269–77.
| Anal carcinoma in human immunodeficiency virus-positive men: results of a prospective study from Germany.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC3M7itlGgtQ%3D%3D&md5=924b71d3f4cc83819717283b84abba4aCAS | 20184584PubMed |

[14]  Palefsky JM, Holly EA, Efirdc JT, Da Costa M, Jay N, Berry JM, et al Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 2005; 19 1407–14.
| Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 16103772PubMed |

[15]  Stier EA, Goldstone SE, Berry JM, Panther LA, Jay N, Krown SE, et al Infrared coagulator treatment of high-grade anal dysplasia in HIV infected individuals: an AIDS malignancy consortium pilot study. J Acquir Immune Defic Syndr 2008; 47 56–61.
| Infrared coagulator treatment of high-grade anal dysplasia in HIV infected individuals: an AIDS malignancy consortium pilot study.Crossref | GoogleScholarGoogle Scholar | 18156992PubMed |

[16]  Pineda CE, Berry JM, Jay N, Palefsky JM, Welton ML. High-resolution anoscopy targeted surgical destruction of anal high-grade squamous intraepithelial lesions: a ten-year experience. Dis Colon Rectum 2008; 51 829–37.
| High-resolution anoscopy targeted surgical destruction of anal high-grade squamous intraepithelial lesions: a ten-year experience.Crossref | GoogleScholarGoogle Scholar | 18363070PubMed |

[17]  Singh JC, Kuohung V, Palefsky JM. Efficacy of trichloroacetic acid in the treatment of anal intraepithelial neoplasia in HIV-positive and HIV-negative men who have sex with men. J Acquir Immune Defic Syndr 2009; 52 474–9.
| 1:CAS:528:DC%2BD1MXhtlygsLnE&md5=d185bbc8a8ca9af16f9ef4d1ce6f4e20CAS | 19779306PubMed |

[18]  Fox PA, Nathan M, Francis N, Singh N, Weir J, Dixon G, et al A double-blind, randomized controlled trial of the use of imiquimod cream for the treatment of anal canal high-grade anal intraepithelial neoplasia in HIV-positive MSM on HAART, with long-term follow-up data including the use of open-label imiquimod. AIDS 2010; 24 2331–5.
| 1:CAS:528:DC%2BC3cXhtFaqsLjN&md5=a688d3cf698d447afdaef56b9f5608bcCAS | 20729710PubMed |

[19]  Richel O, Wieland U, De Vries HJ, Brockmeyer NH, Van Noesel C, Potthoff A, et al Topical 5-fluorouracil treatment of anal intraepithelial neoplasia in human immunodeficiency virus-positive men. Br J Dermatol 2010; 163 1301–7.
| Topical 5-fluorouracil treatment of anal intraepithelial neoplasia in human immunodeficiency virus-positive men.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXisFGltg%3D%3D&md5=a740d7829ec51958018dd7294e4213e0CAS | 20716208PubMed |

[20]  Study of the Prevention of Anal Cancer. Darlinghurst: SPANC; 2011. Available online at: http://www.nchecrsurveys.unsw.edu.au/spanc/ [verified March 2011].